More than two thirds of adults with biologic-eligible severe asthma show sustained improvement without biologics, while a ...
Mexico's health regulator authorized the country's first clinical trial using domestically manufactured CAR-T cells, allowing ...
Durable Complete Response Achieved with Single Administration of Iopofosine I 131 Provides Additional Clinical Support for the Differentiated ...
OneOncology today announced results from a real-world retrospective study of the delivery of tarlatamab, a treatment for ...
The case study demonstrates a durable complete response in a heavily pretreated DLBCL patient after a single administration ...
Tech Times on MSN
Patient dies in BMS multiple sclerosis CAR T trial; company cannot link death to drug
CAR T therapy multiple sclerosis trial death: Bristol Myers Squibb disclosed the first fatality in its Phase 1 Breakfree-2 ...
Autolus Therapeutics looks undervalued as revenue grows and autoimmune catalysts near. Read here for a detailed analysis of ...
At constant scope and exchange rates, revenue was down -3.1% (-3.9% excluding Argentina) in Q3 2026 and by -1.7% (-2.3% excluding Argentina) over 9 months. In Q3, volumes were down, mainly in still ...
A Hong Kong phase II trial of six children found that locally manufactured point-of-care CD19 CAR-T cells, produced in 14 ...
A retrospective study of eleven Chinese children with microtubule-related gene variants links TUBA1A, TUBB2A, TUBB4A and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results